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ARTICLE
PrimPol-dependent single-stranded gap
formation mediates homologous recombination
at bulky DNA adducts
Ann Liza Piberger1✉, Akhil Bowry1,5, Richard D. W. Kelly1,5, Alexandra K. Walker1, Daniel González-Acosta 2,
Laura J. Bailey3, Aidan J. Doherty 3, Juan Méndez 2, Joanna R. Morris 1, Helen E. Bryant4 &
Eva Petermann 1✉
Stalled replication forks can be restarted and repaired by RAD51-mediated homologous
recombination (HR), but HR can also perform post-replicative repair after bypass of the
obstacle. Bulky DNA adducts are important replication-blocking lesions, but it is unknown
whether they activate HR at stalled forks or behind ongoing forks. Using mainly BPDE-DNA
adducts as model lesions, we show that HR induced by bulky adducts in mammalian cells
predominantly occurs at post-replicative gaps formed by the DNA/RNA primase PrimPol.
RAD51 recruitment under these conditions does not result from fork stalling, but rather
occurs at gaps formed by PrimPol re-priming and resection by MRE11 and EXO1. In contrast,
RAD51 loading at double-strand breaks does not require PrimPol. At bulky adducts, PrimPol
promotes sister chromatid exchange and genetic recombination. Our data support that HR at
bulky adducts in mammalian cells involves post-replicative gap repair and define a role for
PrimPol in HR-mediated DNA damage tolerance.
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proper cell response to DNA damage during DNA
replication is essential to maintain genome integrity and
prevent cancer development. Environmental exposures
frequently induce bulky DNA adducts, mutagenic, and carcino-
genic DNA lesions that can pose strong physical obstacles to
DNA replication forks. If not removed by nucleotide excision
repair (NER), then the presence of these adducts on the DNA
template inhibits the replicative polymerase, potentially leading to
replication fork stalling. If stalled forks cannot be restarted, they
can collapse into DNA double-strand breaks (DSBs), which are
highly toxic and/or mutagenic. Fork collapse also activates
homologous recombination (HR) for repair1,2.
HR proteins, such as RAD51, are also involved in the remo-
deling and restart of stalled forks. We previously showed that
replication inhibitors such as hydroxyurea (HU) induce at least
two different RAD51-mediated HR pathways. Stalled forks recruit
small amounts of RAD51 for restart, while HR repair of forks that
have been collapsed into DSBs requires more extensive RAD51
loading and formation of RAD51 foci3. RAD51 functions at
stalled forks have since then been linked to replication fork
reversal4, fork protection by preventing MRE11 resection5, and
promoting continuous replication through interaction with DNA
Pol alpha6. Sources of bulky adducts, such as ultraviolet (UV)
radiation or the environmental mutagen benzo[a]pyrene-diol-
epoxide (BPDE), strongly induce RAD51 foci formation and HR,
suggesting that these lesions stall and collapse forks7–9. However,
bulky DNA lesions can also be bypassed using DNA damage
tolerance pathways, which avoid fork stalling. Fork stalling can be
avoided through re-priming, for example by PrimPol, a recently
described RNA/DNA primase that exerts both DNA/RNA pri-
mase and DNA polymerase activity10 and can re-prime after UV
lesions11–14. Damaged DNA can be bypassed either through
error-prone translesion synthesis (TLS) that is promoted by
proliferating cell nuclear antigen (PCNA) mono-ubiquitination,
or through an error-free damage tolerance pathway that is pro-
moted by PCNA polyubiquitination and also uses recombination
proteins.
This last pathway requires RAD51 and involves template
switching to the undamaged sister chromatid. Mechanistically,
template switching is still poorly understood. It has been pro-
posed to operate either directly at the stalled fork, using fork
reversal, or at post-replicative gaps behind the fork, while the fork
itself continues by de novo re-priming15. In budding yeast, there
is evidence that re-priming and post-replicative gap filling is
preferred over fork reversal, and this pathway has been shown to
involve a double Holliday junction-like intermediate16,17.
Although it has been proposed since the 1970s that re-priming at
DNA lesions can also lead to recombination in mammalian cells,
fork reversal has been reported to be frequent in mammalian
backgrounds4, and may be preferred over re-priming.
Therefore, a longstanding and important mechanistic question
is: where is RAD51 most important for replication bypass of
bulky lesions, at the fork, or behind the fork? Does the observed
HR activity at bulky lesions occur at stalled forks, collapsed forks
or post-replicative gaps, and what are the molecular mechanisms
involved?
To address these questions, we used BPDE-DNA lesions as
models to investigate HR induction at bulky DNA adducts in
human cells. Like UV lesions, BPDE adducts are highly relevant
to human disease. They are induced by the common environ-
mental carcinogen benzo[a]pyrene (B[a]P). B[a]P is one of the
most potent known carcinogens and ubiquitous in barbequed
meat as well as emissions from traffic, industry, stoves, and
cigarette smoke18,19. BPDE adducts cause the specific mutation
signature of smoking-induced lung cancer20,21. They are weak
substrates for NER, and unrepaired adducts are ubiquitously
detectable in the DNA of individuals22,23. BPDE adducts can be
bypassed in both error-free and error-prone manner by TLS
polymerases24,25. However, and in contrast to UV-induced
cyclobutane pyrimidine dimers (CPDs), when replication
encounters lower and more physiologically relevant levels of
BPDE adducts, this predominantly induces HR7,8. BPDE adducts
are thus highly recombinogenic and excellent model lesions for
studying HR at bulky adducts (Fig. 1a).
Using low concentrations of BPDE that are non-toxic and
recombinogenic, we report that RAD51 foci formation and HR
activation in response to bulky DNA adducts can occur inde-
pendently of replication fork stalling or -collapse. In these cases,
RAD51 is recruited onto post-replicative single-stranded gaps
that are generated by the re-priming activity of PrimPol, com-
bined with resection. Our data support that HR activity at bulky
adducts in mammalian cells can be associated with post-
replicative repair and define a role for PrimPol in DNA damage
tolerance.
Results
RAD51 foci form without fork stalling at bulky DNA adducts.
To investigate HR at bulky DNA adducts, U2OS cells were treated
with BPDE for 20 min followed by release into fresh medium.
After this treatment, BPDE lesions persist for more than 24 h due
to slow repair26. We examined a range of concentrations from
low non-cytotoxic (50 nM) to high and cytotoxic doses (500 nM
and 1.65 µM) (Supplementary Fig. 1A). BPDE induced phospho-
S139 histone H2AX (γH2AX) foci that co-localized with 5-
Chlorodeoxyuridine (CldU) foci marking ongoing replication
forks, supporting that the treatment was causing replication stress
(Fig. 1b).
We then proceeded to quantify foci induction by BPDE. In all
experiments, foci were quantified directly at the microscope, and
images shown in the figures are for illustration. γH2AX foci were
induced similarly across all BPDE concentrations and persisted
for at least 24 h, consistent with inefficient repair (Fig. 1c).
RAD51 foci analysis showed that HR was induced over several
days after release from BPDE. In agreement with previous
studies7,8, the percentage of RAD51 foci positive cells were more
strongly increased after release from 50 nM BPDE compared to
higher BPDE doses (Fig. 1d, e). These observations were not
simply due to cell cycle changes, as 50 nM BPDE had minimal
effects on cell cycle distribution, and 500 nM BPDE induced an S
phase rather than a G1 arrest (Supplementary Fig. 1B, C).
Furthermore, the numbers of RAD51 foci per positive cell were
also strongly increased after 50 nM BPDE (Supplementary
Fig. 1D).
We next determined the impact of BPDE treatment on
replication fork slowing and -stalling. This first required
developing optimized CldU and IdU dual pulse-labeling protocols
for DNA fiber analysis. We initially added BPDE with the second
(IdU) label to measure the immediate effect of BPDE on
replication fork progression. Only very high BPDE concentra-
tions (1.65 µM) strongly slowed replication speeds (Supplemen-
tary Fig. 1E). To measure replication fork stalling, we labeled
U2OS cells with CldU before, during, and for 30 min after the
BPDE incubation to detect forks that stalled either during or after
the treatment. Cells were then washed and labeled with IdU to
detect any ongoing forks for a further 20 min (Fig. 1f). Stalled
forks were defined as CldU tracks not followed by an IdU track.
Based on our previous measurements26,27, we calculate that a 20
min treatment with 50 nM BPDE would induce 150 adducts/108
base pairs. If an average replication fork replicates 6 × 104
base pairs28, about 10% of forks would likely encounter a lesion.
However, while higher BPDE concentrations increased fork
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stalling, 50 nM BPDE did not lead to appreciable increase in
stalled forks (Fig. 1f). Similar results were also obtained using fork
asymmetry as a readout for fork stalling (Supplementary Fig. 1F).
This suggested that replication forks could continue progression
on the damaged template under these conditions.
We previously reported that RAD51 recruitment to stalled
forks does not lead to RAD51 foci formation, which instead
requires fork collapse into DSBs3. This raised the question
whether treatment with 50 nM BPDE could cause DSB formation.
Analysis of 53BP1 foci, a DSB marker, and physical detection of
DSBs using pulse-field gel electrophoresis (PFGE) suggested that
50 nM BPDE induced few DSBs, while 500 nM and 1.65 µM
BPDE did induce DSB formation (Fig. 1g, Supplementary Fig. 1G,
H). Interestingly, highly cytotoxic treatment with 1.65 µM BPDE
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may suppress the DSB response downstream of γH2AX, as the
DSBs detected by PFGE did not coincide with RAD51 or 53BP1
foci induction under these conditions (Fig. 1e, g, Supplementary
Fig. 1H). Taken together, these data provided no evidence that
RAD51 foci induced by 50 nM BPDE correlate with DSB
formation. In contrast, RAD51 foci induced by 500 nM BPDE
correlated well with DSB formation (Fig. 1e, g). This posed the
question as to the mechanism and role of RAD51 foci formation
specifically after low dose BPDE treatment.
RAD51 is required to promote fork restart in response to HU
treatment3. In contrast, siRNA depletion of RAD51 did not
increase levels of fork stalling after release from low (50 nM) or
high (1.65 µM) BPDE concentrations (Fig. 1h, i, Supplementary
Fig. 2A). RAD51 can also promote fork slowing or -stalling at
lesions induced by UV or methyl methanesulfonate (MMS)29,30.
However, we found no evidence that RAD51 promotes fork
slowing on BPDE-damaged templates (Supplementary Fig. 2B).
Furthermore, RAD51 is required for the repair of collapsed forks
and prevents DSB accumulation in response to HU3. However,
RAD51 depletion had no major effect on the levels of 53BP1 foci
induced by either 50 nM or 500 nM BPDE (Fig. 1j, Supplemen-
tary Fig. 2C). These experiments provided no evidence that
RAD51 is required to prevent fork collapse, or repair collapsed
forks in response to BPDE lesions.
PrimPol re-priming promotes gap formation at bulky adducts.
RAD51 loading to initiate HR requires the formation of long
stretches of ssDNA that are initially coated with RPA, which is
then exchanged for RAD51. RPA foci analysis showed that
ssDNA was rapidly formed even after release from 50 nM BPDE,
in absence of fork stalling or DSB formation (Supplementary
Fig. 2D, E). RPA foci were resolved between 24 and 48 h after
release from BPDE (Fig. 2a). γH2AX foci were also resolved
between 24 and 48 h after release from BPDE, suggesting that
they mostly mark ssDNA (Supplementary Fig. 2F). RAD51
depletion impaired the resolution of BPDE-induced RPA foci,
suggesting that RAD51 was involved in the repair of BPDE-
induced ssDNA (Fig. 2a).
To specifically test whether ssDNA gaps were formed at BPDE
lesions behind ongoing forks, we used the S1 endonuclease (S1)-
modified fiber assay31. S1-dependent DNA cleavage of ssDNA
gaps or nicks allows to specifically detect these lesions in newly
replicated DNA (Fig. 2b). After DNA fiber labeling, nuclei are
permeabilized and treated with recombinant S1 nuclease before
DNA fiber spreading and staining. The IdU pulse is extended to
50 min in order to capture more events, even though this leads to
CldU/IdU ratios that are skewed upwards compared to what
would be expected based on the labeling times (Fig. 2c,
Supplementary Fig. 3A, B). However, if ssDNA gaps are present
in nascent DNA, the S1-induced DSBs cause further shortening of
the IdU-labeled fibers, thus increasing CldU/IdU ratios compared
to mock-treated samples. Release from 50 nM BPDE, but not
from the solvent, resulted in increased CldU/IdU ratios in S1
treated- compared to mock-treated samples, supporting that
ssDNA gaps were generated behind the fork during replication of
DNA containing BPDE lesions (Fig. 2c). Taken together, these
data suggested that RAD51 is involved in post-replicative repair
and that the RAD51 foci nucleation site might be at regions of
ssDNA away from the ongoing fork. We hypothesized this
ssDNA might form at post-replicative gaps through re-priming of
DNA synthesis downstream of the bulky lesion (Fig. 2d).
We, therefore, investigated a potential role for re-priming in
ssDNA gap formation. The RNA/DNA primase PrimPol was
recently reported to re-prime after UV lesions11–14 and was
therefore a good candidate for promoting ssDNA gap formation
(Fig. 2d). We used siRNA12 to deplete PrimPol in U2OS cells
(Fig. 2e, Supplementary Fig. 3C). We first tested whether PrimPol
re-priming was responsible for the continued fork progression
and lack of fork stalling after treatment with 50 nM BPDE.
Indeed, we observed that 50 nM BPDE induced fork stalling
specifically when PrimPol was depleted (Fig. 2f). Furthermore,
PrimPol depletion prevented ssDNA gap induction behind the
fork as measured by S1 nuclease fiber assay (Fig. 2g, Supplemen-
tary Fig. 3D–F). One caveat is that we did not perform the S1
nuclease fiber assay also under conditions of inhibiting NER and
base excision repair, which both could induce ssDNA gaps and
contribute to S1 fiber shortening after treatment with BPDE.
However, excision repair-induced gaps would occur indepen-
dently of PrimPol, thus not affecting the overall impact of
PrimPol depletion.
PrimPol exerts both DNA/RNA primase and DNA polymerase
activity10. To test whether the PrimPol primase activity is
specifically required for continued replication fork progression
in presence of BPDE, we performed rescue experiments by
ectopically expressing wild type (WT) and primase-dead (CH)
mutant versions of PrimPol11,32 (Fig. 2h). These experiments
were performed both using a U2OS cell line carrying an inducible
shRNA that would not target the ectopic constructs7 (Fig. 2i), as
well as siRNA depletion combined with re-expression of siRNA-
resistant WT or CH mutant PrimPol variants (Supplementary
Fig. 3G). Only WT PrimPol, but not CH PrimPol, could rescue
BPDE-induced fork stalling, supporting that re-priming prevents
BPDE-induced fork stalling (Fig. 2j, Supplementary Fig. 3H, I).
PrimPol re-priming and end processing promote RAD51
loading. We next investigated whether RAD51 foci formation
itself depended on PrimPol-mediated re-priming and ssDNA gap
formation. PrimPol depletion in U2OS cells specifically sup-
pressed BPDE-induced RAD51 foci formation but did not sup-
press spontaneous RAD51 foci (Fig. 3a, b). BrdU incorporation
Fig. 1 Bulky DNA adducts induce RAD51 foci formation in absence of replication fork stalling or -collapse. a Schematic of DNA repair and damage
tolerance pathways induced by low doses of BPDE, which forms bulky adducts on guanine. NER: nucleotide excision repair; TLS: translesion synthesis; HR:
homologous recombination. b Co-localization of γH2AX (green) and replication forks (CldU, red) in U2OS cells after 1 h release from 1650 nM BPDE
treatment for 20min. Images are representative of n= 2. Scale bars: 10 μm. c Percentages of U2OS cells with >8 γH2AX foci after release from increasing
concentrations of BPDE. n= 3 d BPDE-induced RAD51 foci. Images are representative of n= 3. Scale bars: 10 μm. e Percentages of U2OS cells with >5
RAD51 foci after release from increasing concentrations of BPDE. n= 3. f Percentages of stalled forks after release from BPDE. U2OS cells were pulse-
labeled with CldU, treated with BPDE during the CldU pulse, and released into IdU. n= 4 (1650 nM n= 3). g Percentages of cells with >10 53BP1 foci after
release from increasing concentrations of BPDE. n= 3. h Top: Protein levels of RAD51 and α-Tubulin (loading control) in U2OS cells after 48 h depletion
with RAD51 or non-targeting (nonT) siRNA. Images are representative of n= 2. Bottom: Strategy for DNA fiber labeling. i Percentages of stalled forks after
release from 50 nM BPDE as shown in (h) in cells treated with nonT or RAD51 siRNA for 48 h. n= 3. j Percentages of control- or RAD51-depleted U2OS
cells with >10 53BP1 foci after release from 50 nM BPDE. n= 3. Source data are provided as a Source Data file. The means and SEM (bars) of at least three
independent experiments are shown. Asterisks indicate p-values compared to solvent unless indicated otherwise (one-way ANOVA and Dunnett’s test for
C, E, F, G; one-sided student’s t-test for I, J, *p < 0.05, **p < 0.01, ***p < 0.001).
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confirmed that this was not due to cell cycle changes or inhibition
of DNA replication after PrimPol depletion (Fig. 3c, Supple-
mentary Fig. 4A). Ongoing PRIMPOL mRNA depletion over the
time course was confirmed using qRT-PCR (Supplementary
Fig. 4B). Additionally, impaired RAD51 foci formation was also
observed in PrimPol-depleted epithelial lung carcinoma A549
and normal lung fibroblast MRC5 cells, and in PRIMPOL knock-
out MRC5 cells (Supplementary Fig. 4C–E).
We next performed rescue experiments to test whether
PrimPol primase activity is needed for RAD51 foci formation
in presence of BPDE. RAD51 foci formation in PrimPol-depleted
cells could be rescued by ectopic expression of PrimPol WT, but
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not the primase-dead PrimPol CH mutant, again suggesting that
specifically the re-priming activity is required for RAD51 foci
formation (Fig. 3d). Similar results were obtained using siRNA
depletion combined with the expression of siRNA-resistant
PrimPol variants (Supplementary Fig. 4F).
In vitro experiments suggest that PrimPol re-primes around 14
nucleotides downstream of DNA lesions33. Such short ssDNA
gaps would need further resection by nucleases such as MRE11
and Exonuclease 1 (EXO1) to allow for RAD51 foci formation
(Fig. 4a). To investigate the resection of these gaps, we used
single-molecule analysis of resection tracks (SMART)34. Cells
were treated with BrdU for 48 h to BrdU-label all DNA (Fig. 4b).
DNA fiber spreading followed by BrdU immunostaining without
acid denaturation was then used to visualize stretches of ssDNA
(Fig. 4c). BPDE treatment clearly induced ssDNA tracks, which
required both PrimPol and EXO1 (Fig. 4c, d). In contrast, ssDNA
tracks at DSBs induced by etoposide were considerably longer
than BPDE-induced tracks and required EXO1, but not PrimPol
(Supplementary Fig. 5A). This supports that BPDE-induced
ssDNA tracks were not due to resected DSBs. To further
investigate the contribution of resection activities to BPDE-
induced ssDNA track formation, we used PFM01, a chemical
inhibitor of the endonuclease activity of MRE11 (Fig. 4e). PFM01
treatment also reduced the lengths of the ssDNA tracks (Fig. 4e,
f), suggesting that initial short gaps are further extended by
resection through MRE11 and EXO1. MRE11 and EXO1
activities may be additive in promoting the resection of the
ssDNA gaps, which we have not tested.
We then investigated the impact of resection on RAD51 foci
formation, using chemical inhibitors of the exo- and endonu-
clease activities of MRE11 (mirin and PFM01, respectively) as
well as siRNA depletion of EXO1. MRE11 activity and EXO1
were both required for BPDE-induced RAD51 foci formation,
supporting that PrimPol-mediated HR initiation involves resec-
tion (Fig. 4g, h).
PrimPol also promotes RAD51 loading at UV and 4-NQO
adducts. To investigate the relevance of PrimPol re-priming for
HR initiation at other bulky lesions, we used UV-C irradiation to
induce CPD and 6-4 photoproducts and measured the impact on
ssDNA gap formation in the presence and absence of PrimPol
(Fig. 5a). UV-C irradiation induced large amounts of S1
endonuclease-sensitive sites, as the lesion density would be higher
than after 50 nM BPDE at about 150 adducts/106 base pairs35.
While PrimPol depletion induced some S1-sensitive sites in both
mock- and UV-C-irradiated samples, the UV-specific induction
of S1-sensitive sites was reduced after PrimPol depletion (Fig. 5b,
Supplementary Fig. 6A, B). Furthermore, PrimPol was required
for efficient RAD51 foci formation in response to bulky lesions
induced by UV-C, and at bulky DNA adducts induced by the
chemical carcinogen 4-nitroquinolie 1-oxide (4-NQO), which
induces bulky adducts on purines (Fig. 5c, d). PrimPol require-
ment for RAD51 formation after UV-C was overall smaller than
for BPDE and 4-NQO. This may be partly due to recombination
also being initiated by NER activity at UV lesions36. Taken
together, these data suggest that PrimPol-mediated re-priming
generates ssDNA gaps for RAD51 loading at bulky DNA adducts
more widely.
We then investigated whether PrimPol is required for
RAD51 foci formation under conditions where HR is initiated
at DSBs. We used treatments with 2 mM HU for 24 h, or 2 Gy
of ionizing radiation (IR), which both induce DSBs either via
fork collapse or directly3. PrimPol was not required for RAD51
loading in response to DSB-inducing treatments (Fig. 5e, f).
Similarly, treatment with 500 nM BPDE induces predomi-
nantly DSB-associated HR after fork stalling (Fig. 1e–g), and
PrimPol was not required for RAD51 loading in response to
500 nM BPDE (Supplementary Fig. 6C). PrimPol re-priming
still occurred at 500 nM BPDE (Supplementary Fig. 6D, E),
indicating that PrimPol-mediated ssDNA gaps can be chan-
neled into other gap-filling pathways such as TLS. This
observation is consistent with reports that high BPDE damage
loads favor TLS over HR7,8. The lack of a role for PrimPol in
DSB-induced recombination agrees with the standard model of
RAD51 loading onto resected DSB ends, which does not
require any re-priming.
PrimPol promotes HR and sister chromatid exchanges. Finally,
we investigated whether PrimPol-mediated re-priming is required
to support the activation of the complete HR pathway leading to
genetic recombination. Both gene conversion (GC) and sister
chromatid exchanges (SCEs) have been proposed as possible
products of recombination by template switching37,38. SCE for-
mation is usually attributed to collapsed fork repair, but
according to some models, SCEs could also arise from post-
replicative template switching38. We first analyzed BPDE-induced
recombination frequencies using the reporter cell line
SW480SN.3, which harbors the SCneo reporter construct that can
detect recombination by GC or SCE39. 50 nM BPDE induced
measurable recombination in this reporter, and this was reduced
after PrimPol depletion (Fig. 6a, Supplementary Fig. 7A). In
contrast, there was no evidence that PrimPol depletion affected
colony survival or percentage of sub-G1 population after BPDE
treatment, and the impact of RAD51 depletion on survival was
also very small (Fig. 6b, Supplementary Fig. 7B). PrimPol
depletion did also not increase DSB formation after BPDE
Fig. 2 Post-replicative single-stranded DNA gaps are generated at bulky adducts through re-priming by PrimPol. a Percentages of nonT- or RAD51-
siRNA treated U2OS cells with >10 RPA foci after release from BPDE. Release from solvent was 3 h. n= 3. b Schematic of the S1 endonuclease-modified
DNA fiber assay and strategy for DNA fiber labeling. c CldU/IdU ratios after S1-modified DNA fiber assay in cells treated with solvent or 50 nM BPDE as in
(b). S1: S1 endonuclease. Lines represent mean. Data from 3 repeats. d Schematic of RAD51-mediated ssDNA gap repair after re-priming at replication-
blocking lesions. e Protein levels of PrimPol and SMC1 (loading control) after 6 h release from 50 nM BPDE or solvent (-) in U2OS cells after 48 h depletion
with PrimPol or nonT siRNA. kDa: kiloDalton. Representative of n= 3. f Quantification of stalled forks after release from 50 nM BPDE in presence of nonT or
PrimPol siRNA. n= 3. g CldU/IdU ratios after S1-modified DNA fiber assay in cells treated with 50 nM BPDE as in (b) after 48 h of nonT or PrimPol siRNA.
Lines represent mean. Data from 3 repeats. h Top: Protein domain structure of wild type (WT) and primase-dead (CH) PrimPol variants. Bottom: Protocol for
dox-inducible shRNA depletion of endogenous PrimPol and ectopic expression of V5-tagged PrimPol variants. i Protein levels of ectopic V5-tagged WT or
CH PrimPol, endogenous PrimPol (long exposure, lane 1 and 4), and SMC1 (loading control) in U2OS cells after treatment as indicated above. Representative
of n= 3 (-Dox:WT and -Dox:CH n= 2). j Quantification of stalled forks after release from 50 nM BPDE with or without PrimPol shRNA and expression
constructs encoding GFP (-) or WT or CH PrimPol. Fiber labeling was as in (f) n= 3. Source data are provided as a Source Data file. The means and SEM
(bars) of at least three independent experiments are shown. Asterisks indicate p-values compared to solvent unless indicated otherwise (one-sided student’s
t-test for A, F, one-sided Mann–Whitney for C, G; one-way ANOVA for J, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
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treatment (Supplementary Fig. 7C). This is in line with previous
findings that PrimPol-depleted human cells are not very sensitive
to DNA damage induced by UV, suggesting that other pathways
such as TLS or fork regression can compensate12,40. It also sug-
gests that the PrimPol-mediated pathway might predominantly
impact on BPDE-induced mutagenesis and/or the level of geno-
mic rearrangements, rather than cytotoxicity. We further used
microscopy to investigate SCE induction as a read-out for
crossover resolution of recombination events. 50 nM BPDE and
50 nM 4-NQO both clearly induced SCE formation (Fig. 6c–e). In
support of this, PrimPol depletion prevented BPDE- and 4-NQO-
induced SCE formation, while it did not influence the sponta-
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Fig. 3 PrimPol-mediated re-priming promotes RAD51 loading in response to bulky DNA adducts. a RAD51 foci after 24 h release from 50 nM BPDE in
the presence of nonT or PrimPol siRNA. Images are representative of n= 3. Scale bars: 10 μm. b Percentages of U2OS cells with >5 RAD51 foci after release
from 50 nM BPDE, in presence of nonT or PrimPol siRNA. n= 3. c Representative cell cycle distributions after release from solvent (1 h) or 50 nM BPDE in
presence of nonT or PrimPol siRNA. Cells were incubated with BrdU for 30min to label replicating cells prior to flow cytometry. Percentages are means
from three independent experiments as shown in Figure S4A. d Percentages of cells with >5 RAD51 foci after release from 50 nM BPDE, with or without
PrimPol shRNA depletion and expression constructs encoding GFP or WT or CH PrimPol. The release from the solvent was 1 h. n= 3. Source data are
provided as a Source Data file. The means and SEM (bars) of at least three independent experiments are shown. Asterisks indicate p-values (one-sided
student’s t-test for B or one-way ANOVA for D, *p < 0.05, **p < 0.01).
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Discussion
We have shown that during DNA replication of bulky DNA
adducts in mammalian cells, HR activation can occur in absence
of stalled or collapsed replication forks at single-stranded
gaps that are generated by the re-priming activity of PrimPol
(Fig. 6f). This pathway has both similarities and differences to
DSB repair.
Previous work has suggested roles for re-priming and PrimPol
at UV and cisplatin lesions9,11–14,41. It is therefore to be expected
that re-priming also occurs at other bulky lesions. However, our
findings address long-standing questions by showing that at bulky
DNA adducts, RAD51 foci formation and sister chromatid
exchange that have been traditionally connected with replication
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Fig. 4 RAD51 loading at PrimPol-dependent single-stranded DNA gaps requires DNA end resection. a Schematic of MRE11 and EXO1 nuclease activities
and targeting by MRE11 inhibitors PFM01 and mirin. b Top: Strategy for SMART analysis of single-stranded DNA quantifications. Bottom: Protein levels of
EXO1 and α-Tubulin (loading control) in U2OS cells after 48 h depletion with EXO1 or nonT siRNA. Images are from n= 1. c SMART analysis of single-
stranded DNA after release from 20min of 50 nM BPDE or solvent (-) for 4 h, in presence of nonT (-), PrimPol, or EXO1 siRNA. Images are representative
of n= 3. Scale bars: 10 μm. d Quantification of SMART analysis after BPDE as in (c). Lines represent mean. Data from 3 repeats. e Strategy for SMART
analysis with MRE11 inhibitor (MRE11i) PFM01 and representative images of native BrdU tracts. Scale bars: 5 μm. f SMART analysis of single-stranded DNA
after release from 20min of 50 nM BPDE for 4 h, in the presence or absence of MRE11 inhibitor PFM01. Lines represent mean. Data from 3 repeats.
g Percentages of cells with >5 RAD51 foci after release from 50 nM BPDE, in the presence or absence of MRE11 inhibitors mirin or PFM01 as in (e). n= 3.
h Percentages of cells with >5 RAD51 foci after release from 50 nM BPDE, in the presence of nonT or EXO1 siRNA for 48 h. n= 3 Source data are provided
as a Source Data file. The means and SEM (bars) of at least three independent experiments are shown. Asterisks indicate p-values (one-way ANOVA for
D, G, one-sided Mann–Whitney for F, one-sided student’s t-test for H, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
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post-replicative gaps. Furthermore, these post-replicative gaps are
produced by PrimPol, shedding light on the function of PrimPol
during DNA damage tolerance.
Most DNA damaging or replication blocking treatments cause
fork slowing and/or stalling as well as fork reversal4. The pre-
viously described functions of RAD51 at such forks are therefore
likely to be active during most forms of replication stress. How-
ever, we suggest that in addition to fork reversal, fork restart and
the repair of collapsed forks, HR at post-replicative gaps con-
stitutes an additional important function of RAD51 in response
to replication blocks. There could be competition between several
of these pathways. It was recently reported that PrimPol rep-
riming competes with replication fork reversal in response to
cisplatin lesions41. This work also showed that PrimPol mRNA
and protein levels increase over 24 h after cisplatin and UV
treatment, thus favoring repriming over fork reversal as an
adaptive mechanism41. However, this response was specific for
BRCA1-deficient backgrounds41, and our qRT-PCR data show no
increase in PRIMPOL mRNA expression over 24 h after BPDE in
BRCA1-proficient U2OS cells (Supplementary Fig. 4B).
Why are these post-replicative gaps resected and channeled
into HR rather than simply filled by TLS? We speculate that HR
and TLS-dependent gap-filling could compete at ssDNA gaps.
Gap resection might prevent TLS and promote HR, but TLS
might be preferred over resection under high damage load. It will
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Release from 2 Gy IR (h)
Fig. 5 PrimPol promotes RAD51 foci formation specifically in response to bulky adducts. a Strategy for the S1-modified DNA fiber assay with ultraviolet
(UV-C) irradiation. b CldU/IdU ratios after S1-modified DNA fiber assay in cells treated with 5 J/m2 UV-C or mock-treated as in (a), in the presence of
nonT or PrimPol siRNA. Lines represent mean. Data from 4 repeats. c Percentages of cells with >5 RAD51 foci after release from 5 J/m2 UV, in presence of
nonT or PrimPol siRNA. Release from mock-irradiation was 3 h. n= 3. d Percentages of cells with >5 RAD51 foci after treatment with 50 nM 4-nitroquinolie
1-oxide (4-NQO), in presence of nonT or PrimPol siRNA. The release from DMSO was 1 h. n= 3. e Percentages of cells with >5 RAD51 foci after treatment
with 2mM hydroxyurea (HU) for 24 h, in presence of nonT or PrimPol siRNA. n= 3. f Percentages of EdU positive cells with >10 RAD51 foci after release
from 2 Gy ionizing radiation (IR), in the presence of nonT or PrimPol siRNA. Release from mock-irradiation was 2 h. n= 3. Source data are provided as a
Source Data file. The means and SEM (bars) of at least three independent experiments are shown. Asterisks indicate p-values (One-way ANOVA for B;
one-sided student’s t-test for C-F, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
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and the presence of the bulky adduct influence the pathway
decision between TLS and template switching. Future work
could involve examining the impact of PrimPol on PCNA
ubiquitylation.
Our data agree with recent work in budding yeast, reporting
that checkpoint activation by fork-stalling lesions also occurs at
EXO1-resected post-replicative gaps rather than directly at the
fork42. Furthermore, EXO1 resection is downstream of PCNA
polyubiquitylation that promotes template switching. A model
was proposed in which resection of the gap is stimulated by
polyubiquitylated PCNA stuck on the 3′ (upstream) junction and
by the 9-1-1 checkpoint clamp loaded onto the 5′ (downstream)
junction43 (Fig. 6f). The length of BPDE-induced gaps will
require further investigation to determine whether PrimPol can
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With the observed roles for resection and RAD51 foci forma-
tion, HR at bulky adducts seems to resemble DSB repair more
than the known HR functions at stalled forks. It has been
speculated pro-recombination activities could be specifically
recruited to the post-replicative environment at the gap15. These
may promote RAD51 foci formation, and long-range resection
may support a more accurate homology search. In contrast to
stalled replication forks, RAD51 foci formation might be sup-
pressed by anti-recombinogenic helicase activities15 and the
possibilities for remodeling, e.g., by fork reversal (Fig. 6f).
Another unanswered question is the contribution of re-
priming by DNA polymerase α (Pol α) to HR. Pol α is solely
responsible for gap formation in yeast, which lacks PrimPol17. In
mammalian cells, with Pol α constantly re-priming on the lagging
strand and possibly also the leading strand, one would expect at
most half of gap- and RAD51 foci formation to be PrimPol-
dependent. However, PrimPol depletion almost completely
abrogates the BPDE-induced RAD51 foci formation, recombi-
nation, and SCE formation, suggesting that PrimPol is required
for far more than 50% of lesion-induced HR events. We can only
speculate that either Pol α maybe somehow inhibited at bulky
lesions in mammalian cells, or that PrimPol might have addi-
tional roles in promoting HR at gaps, for example by interacting
with DNA repair factors or due to its preference to synthesize
DNA primers12. Interestingly, recent work also suggests that
different DNA damage tolerance pathways may be active at the
leading versus the lagging strand in budding yeast44. It will be
important, if challenging, to further investigate how re-priming
via PrimPol specifically promotes HR-dependent gap repair.
While we have shown that PrimPol re-priming initiates HR at
UV, 4-NQO, and BPDE DNA adducts, it will be interesting to
investigate whether other bulky lesions or replication impedi-
ments can be channeled into this pathway. DNA-protein cross-
links, for example, engage HR for repair45,46 and lead to
template-switching47 raising the question of whether PrimPol
could act at these lesions as well. PrimPol also re-primes at R-
loops and secondary structure-forming sequences48,49, opening
up the possibility that HR in those backgrounds might depend at
least partially on PrimPol. It will be important to test how
commonly PrimPol promotes recombination at other replication-
blocking structures.
Understanding the molecular mechanism of HR induced by
bulky adducts is important for human health. We suggest that
this will be particularly useful to interpret more recent cancer
genomics data. Both BPDE-treated cells and lung cancers harbor
insertion and deletion mutations (indels) of unknown origin.
These are in addition to the point mutations ascribed to error-
prone TLS20,50. Indels could result from replication-associated
HR, such as at restarting forks51, or from defective HR, such as in
BRCA-mutant cancers52. It is therefore important to decipher
which HR pathways are actually induced by bulky adducts.
Furthermore, genetic variants in the HR genes BRCA2 and
RAD52 have been liked to lung cancer susceptibility53,54. It will be
important to investigate the impact of such genetic variants on
HR at ssDNA gaps. A PRIMPOL variant has also been suggested
to play a potential role in cancer55.
Taken together, our data support that a large fraction of
mammalian replication-associated HR can occur after re-priming,
post-replicatively behind the fork.
Methods
Cell lines and reagents. U2OS cells were used as the default cell line unless
indicated otherwise. U2OS, A549, and MRC5 cells were obtained from ATCC. The
SW480SN.356, PrimPol-/- MRC540, and U2OS cell lines carrying doxycycline
(Dox)-inducible PrimPol shRNA11 have been described before. U2OS, U2OS
shPrimPol, A549, and MRC5 were authenticated using 17-locus STR profiling.
Cells were confirmed to be free of Mycoplasma infection and grown in Dulbecco’s
modified Eagle’s Medium (DMEM) with 10% fetal bovine serum in a humidified
atmosphere containing 5% CO2. MRC WT and PrimPol-/- cells were grown in
Minimum Essential Media (MEM) with 15% fetal bovine serum. The media was
additionally supplemented with L-Glutamine (2 mM), Penicillin (50 U/mL), and
Streptomycin (50 μg/mL) for all cell lines. Additionally, SW480SN.3 cells were
grown in hygromycin (50 μM) to maintain the SCneo recombination reporter.
Mirin, PFM01, 4-nitroquinolie 1-oxide (4-NQO), etoposide, and hydroxyurea
(HU) were from Sigma-Aldrich.
BPDE treatment. (+)-anti-B[a]P-7R,8S-dihydrodiol-9S,10R-epoxide (enantiopure,
BPDE) was custom-synthesized by the Biochemical Institute for Environmental
Carcinogens (Grosshansdorf, Germany). For long-term storage, BPDE was solved
in a mixture of 95% tetrahydrofuran (anhydrous, inhibitor-free) and 5% tri-
methylamine (subsequently termed “solvent”) to a concentration of 1.65 mM.
Aliquots were stored in amber glass vials at −80 °C. Freshly thawed and diluted
BPDE aliquots were used to avoid inactivation of the reactive compound BPDE.
Following BPDE treatment, media was removed, and cells were washed with PBS
twice before culturing in fresh media. Solvent treatment was for the same length as
BPDE treatment, and release from solvent was for 0 h unless indicated otherwise.
Immunofluorescence. Cells were fixed with 4% PFA for 10 min and permeabilized
with 0.25% triton X-100 for 5 min at 4 °C followed by blocking with 4% FCS in
PBS. Primary antibodies were rabbit polyclonal anti-RAD51 (Abcam ab63801,
1:800 or Calbiochem PC130, 1:2,000 for IR-induced RAD51 foci), mouse mono-
clonal anti-phospho-Histone H2AX (Ser139) (JBW301, Merck 05-636, 1:1,000),
rabbit polyclonal anti-53BP1 (Bethyl A300-272A, 1:15,000), mouse anti-RPA32
(Merck NA18, 1:500), rat anti-BrdU (BU1/75, Abcam ab6326, 1:250) to detect
CldU. Secondary antibodies were anti-rabbit IgG AlexaFluor 594 (ThermoFisher,
1:500) and anti-mouse IgG AlexaFluor 488 (ThermoFisher, 1:500). For RPA
staining, cells were pre-extracted with CSK buffers (CSK1: 10 mM PIPES, 300 mM
sucrose, 100 mM NaCl, 3 mM MgCl2, CSK2: 0.5% Triton X-100) on ice previous to
PFA fixation. For RAD51 foci detection in response to IR irradiation, cells were
also pre-extracted and subjected to EdU staining to label replicating cells. To this
end, cells were incubated with EdU at a final concentration of 1 μM for 30 min
before staining was carried out as detailed in Click-iT EdU Imaging Kits (Life
Technologies). For co-localization staining, primary and secondary antibodies
against phospho-Histone H2AX were fixed for 10 min with 2% PFA before DNA
denaturation with 2M HCl for 40 min and immunostaining for CldU. DNA was
counterstained with DAPI. Based on the background numbers of foci observed in
unchallenged U2OS cells, cells with more than 5 RAD51 foci (10 foci for IR-
induced RAD51 staining) and 8 γH2AX or 10 53BP1 foci were scored as positive.
Foci were quantified by eye directly on the microscope, and representative images
were taken for illustration.
DNA fiber analysis. U2OS cells were pulse-labeled with 25 μM CldU and 250 μM
IdU, and treated with BPDE for the times indicated. Labeled cells were harvested and
Fig. 6 PrimPol is required for homologous recombination induced by bulky adducts. a Relative recombination frequencies in SW480SN.3 cells induced
by BPDE. Cells were treated with 50 nM BPDE for 20min in presence of nonT or PrimPol siRNA. n= 4 (PrimPol siRNA solvent n= 3). b Colony survival
assay of U2OS cells after 20min treatment with BPDE at the indicated concentrations in presence of nonT, PrimPol or RAD51 siRNA. n= 4 (RAD51 siRNA
n= 3). c Strategy for sister chromatid exchange (SCE) detection and representative picture of metaphase spreads in response to 50 nM BPDE or 4-NQO.
Scale bar: 10 μm. d SCE formation in U2OS cells after treatment with 50 nM BPDE or solvent in the presence of nonT or PrimPol siRNA. Lines represent
mean. Data from 3 repeats. e SCE formation in U2OS cells after treatment with 50 nM 4-NQO or DMSO in the presence of nonT or PrimPol siRNA. Lines
represent mean. Data from 3 repeats. f Model of recombination at bulky DNA adducts. Left: In presence of PrimPol, re-priming creates gaps that are
resected for RAD51 foci formation and recombination repair. Potential TLS events at gaps and recombination not resulting in sister chromatid exchanges
have been omitted for simplicity. Right: In absence of PrimPol, bulky DNA adducts are either bypassed by TLS or alternatively, stalled forks are stabilized by
fork regression and potential rescue upon convergence with another fork. Source data are provided as a Source Data file. The means and SEM (bars) of at
least three independent experiments are shown. Asterisks indicate p-values (one-way ANOVA, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
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DNA fibers were spread by mixing 2 μl cells with 7 μl spreading buffer (200mM
Tris–HCl pH 7.4, 50 mM EDTA, 0.5% SDS). DNA fiber spreads were fixed in 3:1
methanol:acetic acid. Rehydrated spreads were denatured in 2.5M HCl for 80min,
incubated with rat anti-BrdU (BU1/75, Abcam ab6326, 1:700) and mouse anti-BrdU
(B44, Becton Dickinson 347580, 1:500) for 1 h, fixed with 4% PFA and incubated with
anti-rat AlexaFluor 555 (ThermoFisher, 1:500) and anti-mouse AlexaFluor 488
(ThermoFisher, 1:500) for 1.5 h. Fibers were examined using a Nikon E600 micro-
scope with a Nikon Plan Apo 60x (1.3 NA) oil lens, a Hamamatsu digital camera
(C4742-95), and the Volocity acquisition software (Perkin Elmer). For the quantifi-
cation of replication structures, at least 190 structures were counted per experiment.
Stalled forks were defined as CldU tracts not followed by an IdU tract. For quanti-
fication of fork speeds, the lengths of labeled tracks were measured using the ImageJ
software (http://rsbweb.nih.gov/ij/)57 and arbitrary-length values were converted into
μm using a micrometer slide for calibration. Fork stalling was quantified either by
scoring percentages of CldU-only fibers of all red-labeled structures or by comparing
the lengths of IdU tracks of bidirectional forks (fork asymmetry).
S1 endonuclease (S1)-modified DNA fiber assay. U2OS cells were pulse-labeled
with 25 μM CldU and 250 μM IdU, and treated with BPDE for the times indicated
followed by permeabilization with CSK100 buffer (100 mM NaCl, 10 mM MOPS
pH 7.0, 3 mM MgCl2, 300 mM sucrose, 0.5% triton X-100) for 10 min. Nuclei were
subsequently treated with either 20 U/mL S1 endonuclease (Invitrogen, 18001016)
to induce DSBs at sites of DNA gaps or mock-treated (S1 buffer: 30 mM sodium
acetate, 10 mM zinc acetate, 5% glycerol, 50 mM NaCl, pH 4.6) for 30 min at 37 °C.
Nuclei were harvested by scraping and DNA fiber spreads were prepared, stained,
and analyzed as described for the unmodified fibers assay above. At least 120 fibers
per condition were measures from 3 independent biological repeats.
Single-molecule analysis of resection tracks (SMART). U2OS cells were treated
with 20 μM BrdU for 48 h. After treatment with BPDE, siRNA, etoposide, or MRE11
inhibitor as applicable, DNA was spread as for the unmodified DNA fiber assay.
Native fiber spreads were stained with mouse anti-BrdU (B44, Becton Dickinson
347580, 1:500) for 1 h, fixed with 4% PFA, and incubated with anti-mouse AlexaFluor
488 (Thermo Fisher, 1:500) for 1.5 h. Fibers were examined as described above. For
quantification of DNA gap sizes, the lengths of green (AF 488) labeled native patches
were measured using ImageJ and arbitrary-length values were converted into μm
using the scale bars created by the microscope. A total of at least 550 fiber stretches
derived from 3 independent biological repeats were measured.
Pulsed-field gel electrophoresis (PFGE). To detect DSBs, 2 × 106 cells per sample
were treated as indicated, harvested, and melted into 1.0% InCert-Agarose (Lonza)
inserts. Inserts were digested in 0.5 M EDTA-1% N-laurylsarcosyl-proteinase K (1
mg/ml) at room temperature for 48 h and washed three times in TE buffer. Inserts
were loaded onto a separation gel (1.0% chromosomal-grade agarose, Bio-Rad).
The separation was performed using a CHEF DR III (BioRad; 120 field angle, 240 s
switch time, 4 V cm−1, 14 °C) for 20 h. Images of ethidium bromide-stained gels
were acquired using a Syngene G:BOX gel imaging system. DSBs (chromosome
fragments >2 Mbp) were quantified by densitometry using ImageJ and normalized
to the total amount of DNA in the gel.
siRNA and DNA transfection. Custom made siRNAs against RAD5158, and
PrimPol12 were from Dharmacon, and custom made EXO1 siRNA (Sense: GAA
CAA GGU UCC UGG GCU AUA[dT][dT], Antisense: [Phos]UAU AGC CCA
GGA ACC UUG UUC[dT][dT]) was from Sigma-Aldrich. “Allstars negative
control siRNA” was from Qiagen. Cells were transfected for 48 h with 50 nM
siRNA using Dharmafect 1 reagent (Dharmacon). Expression of PrimPol shRNA
was induced with 1 μg/ml Dox for 3 d. For rescue experiments, 2.5 μg of PrimPol
variant expressing pcDNA3.1/nV5-DEST vectors11 or control plasmid pEGFP-C2
(Clontech) were transfected for the last 24 h using TransIT-2020 (Mirus Bio). To
generate siRNA-resistant expression vectors, pcDNA3.1/nV5-DEST vectors
expressing PrimPol WT or CH variant11 were subjected to site-directed muta-
genesis using forward primer CGT CTG TGT ACA GAC CAA GAT TGT CCA
AG; reverse primer ACA AGG GCT TTC TCT CAT AAT GAG ATG CTC and the
Q5® Site-Directed Mutagenesis Kit (New England Biolabs). Cells were transfected
with 50 nM siRNA using Dharmafect 1 for 48 h, and with 2.5 μg siRNA-resistant
expression vectors or pEGFP-C2 using TransIT-2020 for the last 24 h.
Western blotting. Cell extracts were prepared in UTB buffer (50 mM Tris–HCl
pH 7.5, 150 mM β-mercaptoethanol, 8 M urea) and sonicated to release DNA-
bound proteins. Primary antibodies used were rabbit anti-RAD51 (Abcam,
ab63801, 1:1,000), rabbit anti-EXO1 (Bethyl, A302-640, 1:1,000), rabbit anti-
PRIMPOL (described in ref. 11, 1:1000), rabbit anti-SMC1 (a kind gift from A.
Losada’s lab, CNIO59, 1 μg/ml), mouse anti-V5 tag (Invitrogen, R960-25, 1:1:500),
and mouse anti-αTUBULIN (B512, Sigma T6074, 1:10,000).
Quantitative RT-PCR. Total RNA was harvested using the miRNeasy Mini Kit
(Qiagen) followed by DNase I treatment (Roche). 1 µg of total RNA was reverse-
transcribed using SuperScript Reverse Transcriptase III (Thermo Fisher) with
random primers (Promega), following manufacturer’s instructions. The qPCR
primers for amplification are listed in Supplementary Table 1. For quantitative RT-
PCR, 2 µl of cDNA were analyzed using a CFX Connect real-time PCR machine
(BioRad) with SensiFAST SYBR Lo-ROX Kit (Bioline). Cycling parameters were
95 °C for 3 min, followed by 40 cycles of 95 °C for 10 s, 60 °C for 30 s. The result
was normalized to RPLP0. ΔcT was calculated as the difference in the cycle
threshold of the transcript of interest and RPLP0, plotted as fold change compared
to the CTR untreated sample.
Recombination in SW480SN.3 cells. Following siRNA treatments, SW480SN.3
cells were rinsed in PBS and left in fresh non-selective media for 48 h. Cells were
treated with solvent or 50 nM BPDE for 20 min, rinsed in 2x PBS, trypsinized and
directly reseeded. To determine cloning efficiency, two dishes were plated with 500
cells each. For the selection of recombinants cells were grown in G418 (1 mg/ml; 25
cells/mm2) in two technical repeats. After 14–18 days the colonies obtained were
stained with methylene blue in methanol (4 g/l) and the number of recombinants
was calculated per 10−5 colony-forming cells. Recombination frequencies were
normalized to BPDE-treated samples to account for the high variation in spon-
taneous recombination between samples.
Analysis of sister chromatid exchange (SCE). U2OS were incubated with 240
μM BrdU for two cell cycles and treated with BPDE, 4-NQO, and siRNA as
indicated. 4 h before trypsinization, 0.02 μg/mL colcemid (Sigma-Aldrich) was
added. In total 0.075M KCl hypotonic buffer was added to pelleted cells for 15 min
and cells were then fixed in 3:1 methanol:acetic acid. Spreads were prepared by
dropwise addition to a glass slide and left to dry in the dark overnight. Slides with
metaphases were stained in 10 μg/mL Hoechst 33258 in water for 20 min, exposed
to long-wave (365 nm) UV light in a glass dish of 2x SSC buffer (30 mM sodium
citrate, 300 mM NaCl in water) for 8–10 min, and stained in 20% Leishman’s stain
(VWR) diluted in Gurr buffer (Gibco) for 6 min at room temperature. Slides were
analyzed using a Zeiss Axio Observer microscope. SCEs were defined by an
exchange of dark-stained (Hoechst-bound TT-rich) segments with light, bleached
(BrdU incorporated) segments. Staining variation where chromatids clearly twisted
around each other was excluded from the count. For each condition, at least 90
metaphases from at least 3 independent biological repeats were analyzed. SCE rates
were calculated per diploid set of chromosomes to compensate although U2OS
present with chromosome counts in the hypertriploid range. SCEs were quantified
directly on the microscope, and representative images were taken for illustration.
Colony survival assay. U2OS cells were siRNA transfected for 24 h previous to
being plated in triplicates for both 500 and 1000 cells. Cells were given 24 h to
adhere before treatment with BPDE (10–400 nM) for 20 min. Subsequently, cells
were washed 2x PBS and colonies of >50 cells were allowed to form in fresh
medium and fixed in 50% ethanol, 2% methylene blue.
Flow cytometry. U2OS cells were transfected with siRNA for 48 h followed by
treatment with 50 nM BPDE and release into fresh DMEM. Cells were incubated
with 100 μM BrdU for the last 30 min of the indicated release times and then fixed
in 70% ethanol overnight. Cells were incubated in 2M HCl/0.1mg/ml pepsin for 30
min. Samples were washed in PBS before incubation with mouse anti-BrdU (B44,
Becton Dickinson 347580, 1:200) for 1 h and subsequently with anti-mouse IgG
AlexaFluor 488 (ThermoFisher) for 1 h. Finally, cells were incubated with 10 μg/ml
propidium iodide and 25 μg/ml RNaseA for 30 min. Cell cycle profiles were gath-
ered using the BD LSR Fortessa ×20 and analyzed with BD FacsDiva software.
Quantification and statistical analysis. Column graphs represent the means+ 1x
SEM of at least 3 independent biological repeats. Scatter graphs show individual
data points from at least 3 independent biological repeats. The number of inde-
pendent biological repeats (n) is indicated in the figure legends. For foci analysis, at
least 10 different areas with at least 140 cells in total were quantified for each
independent biological repeat. Statistical tests were performed using Graphpad
Prism v6-8 and Microsoft Excel v16. The statistical tests used throughout were the
one-sided student’s t-test, one-sided Mann–Whitney test, or one-way ANOVA
followed by Dunnett, Tukey, or Sidak test. Asterisks compare to control, unless
indicated otherwise by lines or in the figure panels, and signify *p < 0.05, **p <
0.01, ***p < 0.001. ****P < 0.0001.
Reporting Summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Raw data for this study mainly comprise microscopy images of the DNA fiber assay.
These images and all relevant data are available from the authors upon reasonable
request. A reporting summary for this article is available as a Supplementary Information
file. Source data are provided as a Source Data file. Source data are provided with
this paper.
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